Sarraju A, Li J, Cannon CP, Chang TI, et al. Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes in Participants With Type 2 Diabetes and Chronic Kidney Disease According to History of Heart Failure: Results From the CREDENCE Trial. Am Heart J 2020 Dec 20. pii: S0002-8703(20)30407.
PMID: 33358942